Russell

Russell is a Professor in the Department of Neurology at the University of California, San Francisco (UCSF) School of Medicine. As a leading neuroscientist, he focuses on neurodegenerative diseases including Alzheimer's, Parkinson's, and Traumatic Brain Injury (TBI). He directs the Neurodegenerative Disease Research Center and leads the Russell Lab, integrating basic research with clinical translation.

• PhD in Neuroscience from Harvard University (2005)
• MD from Stanford University School of Medicine (2002)

His research investigates neurodegenerative mechanisms using advanced neuroimaging, molecular biology, and computational modeling. Current projects explore tau protein aggregation, blood-brain barrier dysfunction in TBI, and neuroprotective CRISPR-based therapies.

Recent publications emphasize machine learning applications in neurodegenerative diagnosis, novel biomarkers for ALS progression, and LRRK2 kinase inhibitors for Parkinson's treatment. Research trends show strong focus on translational medicine bridging basic science and clinical practice.

• NIH Director’s Pioneer Award (2024)
• Alzheimer’s Association Zenith Fellow (2023)

Directed over $10M in NIH grants, advised 5 PhD students, and collaborates with the Gladstone Institutes. Current grants include a NINDS-funded study on TBI recovery mechanisms and a DoD grant exploring neuroprotection in combat-related injuries.

Leads the Neurodegeneration Imaging Core and collaborates with the UCSF Memory and Aging Center. Future work focuses on developing AI-driven diagnostic platforms and gene-editing therapies for neurodegenerative diseases.